The role of domestic pharmaceutical equipment is changing, from follower to participant

[ Chemical Machinery Equipment Network Market Analysis ] In recent years, with the rapid development of the pharmaceutical industry, the status of domestic pharmaceutical equipment in the entire industry has also undergone significant changes.
Compared with the past, domestic pharmaceutical machinery equipment has better performance, improved innovation capabilities, and more satisfies the needs of domestic pharmaceutical companies, and its recognition has been continuously improved.
It is widely used in the production processes of major pharmaceutical companies.
Behind this series of changes, the role of domestically-made pharmaceutical machines is changing, from followers to participants who originally imitated foreign products, and even toward innovative pioneers.

 

Change from follower to participant
 

With the development and growth of China's pharmaceutical equipment industry, the status of domestic pharmaceutical machinery brands in the transformation and upgrading of pharmaceutical companies is also changing.
Low-level and low-value-added pharmaceutical machinery products are gradually being eliminated.
In the field, some powerful domestic brands are constantly emerging.

 

For example, in the field of freeze-drying, freeze-drying equipment manufacturers through more than ten years of hard work have further shortened the product gap with European and American countries, which is conducive to further accelerating the import substitution of domestic products.

 

In the field of centrifuges , many domestic enterprises have achieved good results and good customer reputation by insisting on continuous innovation in products and technologies.

 

"In our early research and development, we have always regarded'customization' as the core of the company's research and development.
Based on a lot of practical research, we have solved a large number of bottlenecks and technical problems.
We have successively broken through the ultra-high-speed dynamic balance of the spiral rotor and the operation of the whole machine.
The industry’s core technical difficulties such as flapping and stalling; at the same time, through the research of the internal separation mode of the centrifuge, the processing capacity of our equipment, separation energy consumption and other core indicators have exceeded the imported products of the same series.
In addition, we have also formed our own A complete and independent theoretical system has broken the technological monopoly of some brands.
" A centrifuge company said at the 2020 Shanghai Biological Fermentation Exhibition.

 

At the same time, it has become the consensus of domestic pharmaceutical equipment companies to accelerate the market .
For example, the freeze dryer companies mentioned above are also geared towards providing excellent freeze drying equipment, professional industry solutions and high-quality services to continue to create greater value for customers.
It is reported that in the market, the manufacturer also provides some good solutions.

 

According to the 2018 Blue Book of China’s Health Industry, the pharmaceutical equipment industry, as an important branch of the pharmaceutical industry, has made significant progress in exports in recent years.
The average growth rate of the industry’s annual export delivery value has reached 23%, and in 2019 Given that the overall market of the pharmaceutical equipment industry is better than expected, the export market will continue to expand in the future.

 

　　It can be seen that the strength of domestic pharmaceutical equipment is rising, and the role it plays is gradually changing from a follower to a participant.

 

　　Two major bottlenecks need to be broken
 

　　"Drying boxes, high-pressure steam sterilizers and other common and commonly used equipment in pharmaceutical companies, such products are actually not worse than imported ones.
" Some pharmaceutical robots said that domestic pharmaceutical equipment is developing in a stronger and stronger direction, but at the same time, there are several major bottlenecks that need to be seen.

 

　　On the one hand, the lack of pharmaceutical machinery in the Chinese market is serious.
According to the "In-Depth Market Research and Investment Strategy Recommendation Report for the Pharmaceutical Equipment Industry for 2020-2024" released by the New Sijie Industry Research Center, at present, domestic pharmaceutical equipment has basically achieved import substitution in the low-end market, but there is still a need for further progress in the market.
Strengthen the breakthrough.

 

　　Analyzing the reasons behind it, the main reasons are the lack of core technology of domestic pharmaceutical machinery and the weak scientific research foundation, which makes the overall product technical performance still have some gaps compared with overseas brands, and even some important parts and core technologies still rely on imports, so domestic production Pharmaceutical machinery companies urgently need to increase investment in innovation and research and development to break the "stuck neck" link.

 

　　At the same time, it is also necessary to strengthen the R&D opportunities for core technology and key component manufacturing, encourage enterprises to in-depth cooperation with colleges and universities, scientific research institutions, and promote the development of industrialization and intelligent transformation.

 

　　On the other hand, there is a shortage of professionals.
In addition to the lack of core technology, the talent bottleneck of the domestic pharmaceutical machinery industry is also in urgent need of breakthrough.
The problem of "cannot find, recruit, and retain" talents for enterprises needs to be solved.
Only by strengthening the training of core technical and management personnel can we make new Technology and new thinking continue to derive and iterate, inject strong and lasting impetus into the company's core technology, manufacturing process and service concept to continuously update, thereby promoting the development of the entire pharmaceutical equipment industry in the direction.

 

　　The author has learned that in order to promote the development of my country's pharmaceutical machinery industry, relevant policies have been frequently released in recent years.
For example, in September this year, the "Guiding Opinions on Expanding Strategic Emerging Industry Investment, Cultivating and Growing New Growth Pole Growth Pole" jointly issued by my country's four departments proposed that the equipment manufacturing industry should speed up to make up for shortcomings.
The key supported projects involve the production of equipment such as medical equipment and pharmaceutical equipment, and the implementation of smart manufacturing and smart construction pilot demonstrations.

 

　　Conclusion
 

　　In general, with the intensification of aging and the rapid expansion of demand in the pharmaceutical market, pharmaceutical equipment, as the "mother machine" for pharmaceutical companies, has good development opportunities.
At present, domestic pharmaceutical equipment still accounts for a small market share, and there is a large room for import substitution in the future.
It is believed that with the joint efforts of the industry and enterprises, the role of the domestic pharmaceutical machine brand in the pharmaceutical equipment industry will gradually change from a follower to a participant, and to an innovative pioneer.

 

　　Original title: The role of domestic pharmaceutical equipment is changing, from follower to participant